Results 261 to 270 of about 334,918 (302)

Liquid biomarkers in active surveillance

World Journal of Urology, 2021
In the past two decades, new biomarkers for prostate cancer detection and risk prediction have become available for clinical use. While tissue-based gene expression assays offer molecular risk assessment after diagnoses, several serum- and urine-based 'liquid' biomarkers are available for the pre-biopsy setting which may also play a role for active ...
openaire   +2 more sources

Not So “Active” Surveillance

International Journal of Radiation Oncology*Biology*Physics, 2021
Christopher J D, Wallis, Laurence, Klotz, Raj, Satkunasivam, Zachary, Klaassen   +3 more
openaire   +2 more sources

Psychosocial aspects of active surveillance

Current Opinion in Urology, 2013
To summarize the literature on psychosocial responses to active surveillance as well as educational and support strategies to promote adherence.There are two prevalent responses among men undergoing active surveillance; anxiety and uncertainty. The education of a patient about low-risk prostate cancer as well as the inquiry by the physician into ...
Meredith W, Kazer, Sarah P, Psutka, David M, Latini, Donald E, Bailey   +3 more
openaire   +2 more sources

Active surveillance and radical prostatectomy

European Journal of Cancer, 2011
With the awareness on prostate cancer (PCa) and the ever-growing elderly population in Europe, the number of newly diagnosed cancers has increased steadily during the last decade. Early detection leads to a stage shift in which many of these cancers are claimed to be indolent. In early detection programmes the number of these cancers, that likely never
openaire   +2 more sources

A Brief Survey of Active Surveillance

European Urology, 2015
In certain parts of theworld, the ubiquity of prostate-specific antigen (PSA) use in the screening or early detection of prostate cancer (PCa) has led to several downstream phenomena, including the cliches of overdiagnosis and overtreatment of clinically insignificant disease.
openaire   +2 more sources

Active Surveillance for Prostate Cancer

Urologic Clinics of North America
Active surveillance (AS), first described as a management strategy for favorable risk prostate cancer more than 20 years ago has now been widely adopted as the treatment of choice for these patients. AS surveillance initially consisted of regular PSA monitoring with periodic biopsies, with intervention indicated for rapid rise in PSA or upgrading ...
openaire   +2 more sources

Active Surveillance Doing Well Under Surveillance

European Urology Oncology, 2020
O’Connor Ellen, Kapoor Jada, Teh Jiasian, Lawrentschuk Nathan, G. Murphy Declan   +4 more
openaire   +2 more sources

Prostate Cancer and Active Surveillance

2008
This review outlines the different treatment options in localized prostate cancer. This information can be considered alongside other important factors, such as the individual patient's values and situation as well as the potential impact of treatment on his quality of life, in the treatment decision-making process.
openaire   +2 more sources

The Future of Active Surveillance

2012
The majority of men today are diagnosed with early stage, low-grade, localized prostate cancer. The greatest danger to these patients is overtreatment in the face of indolent disease, leaving active surveillance an attractive option. Unfortunately, the ideal markers for disease prognosis, progression, and treatment in the group of men are unknown ...
Sima P. Porten, Jared M. Whitson, Peter R. Carroll   +2 more
openaire   +1 more source

Pushing the Envelope for Active Surveillance

JAMA Oncology, 2022
Andrea L, Merrill, Priya H, Dedhia
openaire   +2 more sources